CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale EVP, Chief Development Officer sold 7,463 shares at $1.42 ($10,612)
- 4 Open-market sale Chief Business Officer sold 4,206 shares at $1.42 ($5,982)
- 4 Open-market sale President and CEO sold 14,911 shares at $1.42 ($21,206)
- 4 Open-market sale General Counsel sold 5,602 shares at $1.42 ($7,968)
- 4 Open-market sale Chief Medical Officer sold 5,602 shares at $1.42 ($7,965)
- 4 Open-market sale Chief Financial Officer sold 3,949 shares at $1.42 ($5,617)
- 8-K Event Exit or restructuring costs · Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 41 · 801 filings